Wegovy's 57% heart risk reduction boosts Novo Nordisk stock; Lilly's Zepbound faces new competition.
E3 triggers Iran sanctions snapback! Expect oil price spikes of 3-75% on supply disruptions. Traders watch geopolitical risks.
NVDA sees $867M retail inflow despite bearish outlooks; PLTR draws $300M. Traders eye Q2 results.
Rhode Island's 'Taylor Swift Tax' hits wealthy homeowners with $337K annual cost, sparking state-wide debate.
SPOT surges 52% YTD, but valuation is high (53x EV/EBITDA). LYV up 28%, trades at 113x earnings. UMGNF gains 10%, trades at 17x EV/EBITDA.
AMZN lags S&P 500 YTD, but AWS & ads growth (17.5%, 22% YoY) plus margin gains (7.5%, 4.1%) signal upside. Wall St. rates it a Strong Buy.
Trump family's $750M crypto deal sparks debate ahead of WLFI token launch. Regulatory scrutiny looms.

7 months ago
36








English (US) ·